Correction To: Comparison Between Breast Conserving Therapy and Oncoplastic Reduction Mammaplasty: a Retrospective Study

Oncoplastic reduction mammoplasty (ORM) allows greater margins without compromising breast shape in comparison to breast conserving therapy (BCT). However, the long-term influence of this treatment on cancer recurrence remains unclear. The benefits of ORM in comparison to BCT were reviewed by conducting a retrospective review of 215 patients. Data on patient demographics, comorbidities, cancer histology, tumour size, receptor status, neoadjuvant or adjuvant therapies, surgical intervention duration, width of the microscopic and macroscopic narrowest margins, need for surgical re-excision or completion of mastectomy, morbidity, duration of hospital stay, recurrence, and mortality rate were gathered and analysed. Two hundred fifteen patients with breast cancer were analysed: 58.1